Schwartz SL - Search Results

1

The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus.

Garcia-Soria G, Gonzalez-Galvez G, Argoud GM, Gerstman M, Littlejohn TW 3rd, Schwartz SL, O'Farrell AM, Li X, Cherrington JM, Bennett C, Guler HP. Garcia-Soria G, et al. Among authors: schwartz sl. Diabetes Obes Metab. 2008 Apr;10(4):293-300. doi: 10.1111/j.1463-1326.2008.00868.x. Diabetes Obes Metab. 2008. PMID: 18333888 Clinical Trial.

2

Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.

Li J, Klemm K, O'Farrell AM, Guler HP, Cherrington JM, Schwartz S, Boyea T. Li J, et al. Curr Med Res Opin. 2010 Aug;26(8):2003-10. doi: 10.1185/03007995.2010.491266. Curr Med Res Opin. 2010. PMID: 20583949 Clinical Trial.

3

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients.

Jabri N, Schalch DS, Schwartz SL, Fischer JS, Kipnes MS, Radnik BJ, Turman NJ, Marcsisin VS, Guler HP. Jabri N, et al. Among authors: schwartz sl. Diabetes. 1994 Mar;43(3):369-74. doi: 10.2337/diab.43.3.369. Diabetes. 1994. PMID: 8314009

4

MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin.

Bays HE, Schwartz S, Littlejohn T 3rd, Kerzner B, Krauss RM, Karpf DB, Choi YJ, Wang X, Naim S, Roberts BK. Bays HE, et al. J Clin Endocrinol Metab. 2011 Sep;96(9):2889-97. doi: 10.1210/jc.2011-1061. Epub 2011 Jul 13. J Clin Endocrinol Metab. 2011. PMID: 21752880 Clinical Trial.

5

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).

Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu PL, Braceras R, Wynne A. Raskin P, et al. Among authors: schwartz sl. Diabetes Obes Metab. 2009 Jan;11(1):27-32. doi: 10.1111/j.1463-1326.2007.00796.x. Epub 2007 Oct 17. Diabetes Obes Metab. 2009. PMID: 17941873 Clinical Trial.

6

Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes.

Henry RR, Smith SR, Schwartz SL, Mudaliar SR, Deacon CF, Holst JJ, Duan RY, Chen RS, List JF. Henry RR, et al. Among authors: schwartz sl. Diabetes Obes Metab. 2011 Sep;13(9):850-8. doi: 10.1111/j.1463-1326.2011.01417.x. Diabetes Obes Metab. 2011. PMID: 21554520 Clinical Trial.

7

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.

Ettinger MP, Littlejohn TW, Schwartz SL, Weiss SR, McIlwain HH, Heymsfield SB, Bray GA, Roberts WG, Heyman ER, Stambler N, Heshka S, Vicary C, Guler HP. Ettinger MP, et al. Among authors: schwartz sl. JAMA. 2003 Apr 9;289(14):1826-32. doi: 10.1001/jama.289.14.1826. JAMA. 2003. PMID: 12684362 Clinical Trial.

8

Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes.

Rosenstock J, Aggarwal N, Polidori D, Zhao Y, Arbit D, Usiskin K, Capuano G, Canovatchel W; Canagliflozin DIA 2001 Study Group. Rosenstock J, et al. Diabetes Care. 2012 Jun;35(6):1232-8. doi: 10.2337/dc11-1926. Epub 2012 Apr 9. Diabetes Care. 2012. PMID: 22492586 Free PMC article. Clinical Trial.

9

The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes.

Amiel SA, Heller SR, Macdonald IA, Schwartz SL, Klaff LJ, Ruggles JA, Weyer C, Kolterman OG, Maggs DG. Amiel SA, et al. Among authors: schwartz sl. Diabetes Obes Metab. 2005 Sep;7(5):504-16. doi: 10.1111/j.1463-1326.2004.00417.x. Diabetes Obes Metab. 2005. PMID: 16050943 Clinical Trial.

10

Safety, pharmacokinetic, and pharmacodynamic profiles of ipragliflozin (ASP1941), a novel and selective inhibitor of sodium-dependent glucose co-transporter 2, in patients with type 2 diabetes mellitus.

Schwartz SL, Akinlade B, Klasen S, Kowalski D, Zhang W, Wilpshaar W. Schwartz SL, et al. Diabetes Technol Ther. 2011 Dec;13(12):1219-27. doi: 10.1089/dia.2011.0012. Epub 2011 Aug 19. Diabetes Technol Ther. 2011. PMID: 21854192 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page